Tony Butler
Stock Analyst at Rodman & Renshaw
(0.57)
# 4,066
Out of 5,182 analysts
88
Total ratings
27.38%
Success rate
-22.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $4.99 | +401.00% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.78 | +295.68% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.91 | +842.41% | 4 | Sep 26, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $2.30 | +595.65% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.35 | +640.74% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $55.54 | +35.04% | 8 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.37 | +15,998.74% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $2.84 | +357.75% | 6 | Aug 7, 2023 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $50 | $4.93 | +914.20% | 5 | Aug 3, 2023 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $15 | $2.32 | +546.55% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $1,250 | $5.64 | +22,063.12% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.71 | +777.19% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.81 | +162.47% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $0.60 | +2,711.78% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.91 | +4,145.52% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $1.86 | +3,125.81% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.48 | +16,116.22% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.16 | +3,721.66% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $0.38 | +94,388.19% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $2.46 | -18.70% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.69 | +2,073.91% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.56 | +541.03% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.24 | +186.26% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $15.31 | +618.48% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $10.77 | +8,813.65% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $4.99
Upside: +401.00%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.78
Upside: +295.68%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.91
Upside: +842.41%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $2.30
Upside: +595.65%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.35
Upside: +640.74%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $55.54
Upside: +35.04%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.37
Upside: +15,998.74%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $2.84
Upside: +357.75%
Bicycle Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $4.93
Upside: +914.20%
Allogene Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $2.32
Upside: +546.55%
Aug 2, 2023
Reiterates: Buy
Price Target: $1,250
Current: $5.64
Upside: +22,063.12%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.71
Upside: +777.19%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $3.81
Upside: +162.47%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $0.60
Upside: +2,711.78%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.91
Upside: +4,145.52%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $1.86
Upside: +3,125.81%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.48
Upside: +16,116.22%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.16
Upside: +3,721.66%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $0.38
Upside: +94,388.19%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $2.46
Upside: -18.70%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $0.69
Upside: +2,073.91%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.56
Upside: +541.03%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $5.24
Upside: +186.26%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $15.31
Upside: +618.48%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $10.77
Upside: +8,813.65%